#321: Dave Feldman & Alan Flanagan – Debating LDL Causality & the “Lipid Triad”

1:58:05
 
Share
 

Manage episode 254487296 series 90069
By Danny Lennon. Discovered by Player FM and our community — copyright is owned by the publisher, not Player FM, and audio is streamed directly from their servers. Hit the Subscribe button to track updates in Player FM, or paste the feed URL into other podcast apps.

Dave Feldman is a software engineer and runs the Cholesterol Code website. In 2015 Dave adopted a low-carb high-fat diet, which improved his overall health. However, upon seeing his LDL-cholesterol skyrocket, he set out learn all he could about blood lipids and health.

Dave has gained prominence as a “LDL-skeptic” and promoter of his “lipid triad” hypothesis. This lipid triad relates to a situation where one sees high LDL-C, high HDL-C and low triglycerides. Dave hypothesises that in such a context, the high LDL-C does not confer high risk of cardiovascular disease. This is counter to the current consensus position of the lipid hypothesis, where LDL plays a causal role in atherosclerosis development.

Alan Flanagan is the Research Communication Officer here at Sigma Nutrition. Alan is currently pursuing his PhD in nutrition at the University of Surrey, UK, with a research focus in chrononutrition. Alan previuosly completed a Masters in Nutritional Medicine at the same institution.

SHOW NOTES: https://sigmanutrition.com/episode321

358 episodes